Found 4 matching trials
IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer
PHASE1This study is for patients with advanced or metastatic gastric cancer whose...
Location
The First Affiliated Hospital of Zhengzhou University
IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer
PHASE3This is an open-label, multicenter Phase 3 study to evaluate the safety and...
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Study of IBI363 Combination Therapy in Participants With Advanced Solid Tumors
PHASE2CIBI363A203, a Phase 2 study to evaluate the safety, tolerability and preli...
Location
Tongji Hospital affiliated to Tongji Medical College HUST
A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal Cancer
PHASE1A Phase 1 study of IBI363 in combination with Bevacizumab or Furuitinib in ...
Location
Union Hospital, Tongji Medical College, Huazhong University Hospital